Similarly, LINC01857 has been revealed to promote progression in cancers, such as glioma [57], B-cell lymphoma [58], and breast cancer, and predict the poor prognosis of breast cancer patients [59]. This evidence concerns the gene LINC01857 and B-cell non-Hodgkin lymphoma.